126 related articles for article (PubMed ID: 15164250)
1. Detection of lymphatic micrometastases in patients with stages I and II colorectal cancer: impact on five-year survival.
Kronberg U; López-Kostner F; Soto G; Zúñiga A; Wistuba I; Miranda V; Pinto E; Viviani P; Marshall G
Dis Colon Rectum; 2004 Jul; 47(7):1151-7. PubMed ID: 15164250
[TBL] [Abstract][Full Text] [Related]
2. Micrometastases and survival in stage II colorectal cancer.
Liefers GJ; Cleton-Jansen AM; van de Velde CJ; Hermans J; van Krieken JH; Cornelisse CJ; Tollenaar RA
N Engl J Med; 1998 Jul; 339(4):223-8. PubMed ID: 9673300
[TBL] [Abstract][Full Text] [Related]
3. Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer.
Sarli L; Bader G; Iusco D; Salvemini C; Mauro DD; Mazzeo A; Regina G; Roncoroni L
Eur J Cancer; 2005 Jan; 41(2):272-9. PubMed ID: 15661553
[TBL] [Abstract][Full Text] [Related]
4. Pathologic determinants of survival after resection of T3N0 (Stage IIA) colorectal cancer: proposal for a new prognostic model.
Cianchi F; Messerini L; Comin CE; Boddi V; Perna F; Perigli G; Cortesini C
Dis Colon Rectum; 2007 Sep; 50(9):1332-41. PubMed ID: 17429709
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of micrometastases in colon cancer: interim results of a prospective multicenter trial.
Bilchik AJ; Hoon DS; Saha S; Turner RR; Wiese D; DiNome M; Koyanagi K; McCarter M; Shen P; Iddings D; Chen SL; Gonzalez M; Elashoff D; Morton DL
Ann Surg; 2007 Oct; 246(4):568-75; discussion 575-7. PubMed ID: 17893493
[TBL] [Abstract][Full Text] [Related]
6. Free colorectal cancer cells on the peritoneal surface: correlation with pathologic variables and survival.
Baskaranathan S; Philips J; McCredden P; Solomon MJ
Dis Colon Rectum; 2004 Dec; 47(12):2076-9. PubMed ID: 15657657
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of micrometastases in esophageal and colorectal carcinoma (a clinical experience).
Laso CA; González JJ; Fresno F; Azcano E; Sanz L; Navarrete F
Hepatogastroenterology; 2004; 51(58):964-7. PubMed ID: 15239225
[TBL] [Abstract][Full Text] [Related]
8. The prognostic effect of micrometastases in previously staged lymph node negative (N0) colorectal carcinoma: a meta-analysis.
Iddings D; Ahmad A; Elashoff D; Bilchik A
Ann Surg Oncol; 2006 Nov; 13(11):1386-92. PubMed ID: 17009147
[TBL] [Abstract][Full Text] [Related]
9. Tumor invasion of lymph node capsules in patients with Dukes C colorectal adenocarcinoma.
Yano H; Saito Y; Kirihara Y; Takashima J
Dis Colon Rectum; 2006 Dec; 49(12):1867-77. PubMed ID: 17080279
[TBL] [Abstract][Full Text] [Related]
10. The impact of anastomotic leak and intra-abdominal abscess on cancer-related outcomes after resection for colorectal cancer: a case control study.
Eberhardt JM; Kiran RP; Lavery IC
Dis Colon Rectum; 2009 Mar; 52(3):380-6. PubMed ID: 19333035
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of lymph node involvement in pulmonary metastases from colorectal cancer.
Welter S; Jacobs J; Krbek T; Poettgen C; Stamatis G
Eur J Cardiothorac Surg; 2007 Feb; 31(2):167-72. PubMed ID: 17150367
[TBL] [Abstract][Full Text] [Related]
12. Incidence and prognostic influence of lymph node micrometastases in rectal cancer.
Fleming FJ; Hayanga AJ; Glynn F; Thakore H; Kay E; Gillen P
Eur J Surg Oncol; 2007 Oct; 33(8):998-1002. PubMed ID: 17287104
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical detection of mutant p53 protein in regional lymph nodes is associated with adverse outcome in stage II colorectal cancer.
Clarke G; Ryan E; Crowe J; O'Keane JC; MacMathúna P
Eur J Histochem; 1999; 43(4):311-6. PubMed ID: 10682269
[TBL] [Abstract][Full Text] [Related]
14. The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma.
Jeffers MD; O'Dowd GM; Mulcahy H; Stagg M; O'Donoghue DP; Toner M
J Pathol; 1994 Feb; 172(2):183-7. PubMed ID: 7513353
[TBL] [Abstract][Full Text] [Related]
15. Impact of microscopic hepatic lymph node involvement on survival after resection of colorectal liver metastasis.
Laurent C; Sa Cunha A; Rullier E; Smith D; Rullier A; Saric J
J Am Coll Surg; 2004 Jun; 198(6):884-91. PubMed ID: 15194069
[TBL] [Abstract][Full Text] [Related]
16. Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system.
Kahn HJ; Hanna WM; Chapman JA; Trudeau ME; Lickley HL; Mobbs BG; Murray D; Pritchard KI; Sawka CA; McCready DR; Marks A
Breast J; 2006; 12(4):294-301. PubMed ID: 16848838
[TBL] [Abstract][Full Text] [Related]
17. Colorectal cancer staging: reappraisal of N/PN classification.
Vaccaro CA; Bonadeo FA; Benati ML; Quintana GM; Rubinstein F; Mullen E; Telenta M; Lastiri JM
Dis Colon Rectum; 2004 Jan; 47(1):66-9. PubMed ID: 14719153
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical assessment of localization and frequency of micrometastases in lymph nodes of colorectal cancer.
Noura S; Yamamoto H; Miyake Y; Kim Bn; Takayama O; Seshimo I; Ikenaga M; Ikeda M; Sekimoto M; Matsuura N; Monden M
Clin Cancer Res; 2002 Mar; 8(3):759-67. PubMed ID: 11895906
[TBL] [Abstract][Full Text] [Related]
19. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
[TBL] [Abstract][Full Text] [Related]
20. Influence of subclinical tumor spreading on survival after curative surgery for colorectal cancer.
Steinert R; Hantschick M; Vieth M; Gastinger I; Kühnel F; Lippert H; Reymond MA
Arch Surg; 2008 Feb; 143(2):122-8. PubMed ID: 18283136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
